NCT03924401 Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03921684 Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03920267 Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT03918252 Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03907852 Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03906071 Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT03894891 Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer Status COMPLETED Phase PHASE2
NCT03891524 A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery Status COMPLETED Phase PHASE2
NCT03891108 A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03890809 An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage Status COMPLETED Phase PHASE1
NCT03890770 A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease. Status COMPLETED Phase PHASE1
NCT03882008 A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT03881059 Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE2
NCT03879811 Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03879122 A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT03878979 Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN Status COMPLETED Phase PHASE2
NCT03873415 Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males Status COMPLETED Phase PHASE1
NCT03873402 A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3